Deferasirox (ICL670) IC50 for Cell-based and Cell-free Assays

Deferasirox (ICL670) is a potent iron chelator. It affects PI3K/AKT/mTOR and STAT1 signaling pathways by binding to intracellular iron and depleting iron stores, effectively inhibiting cancer cell proliferation, stemness, and inducing apoptosis.

🎯 check Deferasirox (ICL670) product page